匹多莫德口服液联合蒲地兰消炎口服液治疗儿童手足口病
的临床研究
朱霞;黄东生;田朝霞;吴昱东;张伟令;王一卓;张谊;周燕;李静
【期刊名称】《现代药物与临床》 【年(卷),期】2017(032)003
【摘要】Objective To explore the clinical value of Pidotimod Oral Solution combined with Pudilan Antiphlogistic Oral Liquid in treatment of children with hand-foot-and-mouth disease.MethodChildren (84 cases) with hand-foot-and-mouth disease in Beijing Tongren Hospital, CMU from May 2014 to May 2016 were randomly divided into control and treatment groups, and each group had 42 cases. Children in the control group were poadministered with Pudilan Antiphlogistic Oral Liquid, 5 mL/time for under 1 year old children, 6.7 mL/time for 1 — 3 years old children, and 10 mL/time for over 3 years old children, three times daily. Children in the treatment group were poadministered with Pidotimod Oral Solution on the basis of the control group, 400 mg/time, twice daily. Children in two groups were treated for 6 d. After treatment, the clinical efficacy, total disease course, average disappearance time of symptoms, and change of blood routine and serum CRP in two groups were compared.Results After treatment, the clinical efficacies in the control and treatment groups were 88.10% and 97.62%, respectively, and there was difference between two groups (P < 0.05). After
匹多莫德口服液联合蒲地兰消炎口服液治疗儿童手足口病的临床研究
